Clonality of Fluconazole-Nonsusceptible Candida tropicalis in Bloodstream Infections, Taiwan, 2011-2017.
Taiwan
azoles
candidemia
drug resistance
fungi
multilocus sequence typing
phylogeny
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
entrez:
24
8
2019
pubmed:
24
8
2019
medline:
29
1
2020
Statut:
ppublish
Résumé
Candida tropicalis is the leading cause of non-C. albicans candidemia in tropical Asia and Latin America. We evaluated isolates from 344 patients with an initial episode of C. tropicalis candidemia. We found that 58 (16.9%) patients were infected by fluconazole-nonsusceptible (FNS) C. tropicalis with cross resistance to itraconazole, voriconazole, and posaconazole; 55.2% (32/58) of patients were azole-naive. Multilocus sequence typing analysis revealed FNS isolates were genetically closely related, but we did not see time- or place-clustering. Among the diploid sequence types (DSTs), we noted DST225, which has been reported from fruit in Taiwan and hospitals in Beijing, China, as well as DST376 and DST505-7, which also were reported from hospitals in Shanghai, China. Our findings suggest cross-boundary expansion of FNS C. tropicalis and highlight the importance of active surveillance of clinical isolates to detect dissemination of this pathogen and explore potential sources in the community.
Identifiants
pubmed: 31441426
doi: 10.3201/eid2509.190520
pmc: PMC6711239
doi:
Substances chimiques
Antifungal Agents
0
Fluconazole
8VZV102JFY
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1660-1667Références
J Clin Microbiol. 2012 Sep;50(9):2846-56
pubmed: 22740712
J Clin Microbiol. 2005 Nov;43(11):5593-600
pubmed: 16272492
Clin Microbiol Infect. 2015 Oct;21(10):946-53
pubmed: 26100373
Emerg Microbes Infect. 2017 Oct 11;6(10):e87
pubmed: 29018251
Infect Genet Evol. 2016 Oct;44:418-424
pubmed: 27456280
Antimicrob Resist Infect Control. 2017 Mar 11;6:27
pubmed: 28293420
J Clin Microbiol. 2013 Jan;51(1):268-77
pubmed: 23152555
J Infect Dis. 2017 Aug 15;216(suppl_3):S445-S451
pubmed: 28911043
Curr Opin Infect Dis. 2017 Dec;30(6):528-538
pubmed: 29095200
BMC Infect Dis. 2018 Apr 10;18(1):162
pubmed: 29631565
J Clin Microbiol. 2018 Mar 26;56(4):
pubmed: 29212705
J Microbiol Immunol Infect. 2018 Feb;51(1):1-17
pubmed: 28781150
Nature. 2009 Jun 4;459(7247):657-62
pubmed: 19465905
J Antimicrob Chemother. 2003 Jul;52(1):71-7
pubmed: 12775680
Antimicrob Agents Chemother. 2014 Jul;58(7):3814-9
pubmed: 24752274
Mycoses. 2015 Sep;58(9):544-9
pubmed: 26214171
J Fungi (Basel). 2017 May 17;3(2):
pubmed: 29371542
Med Mycol. 2016 Jul 1;54(5):471-7
pubmed: 26868904
Clin Microbiol Rev. 2007 Jan;20(1):133-63
pubmed: 17223626
Sci Transl Med. 2012 Dec 19;4(165):165rv13
pubmed: 23253612
J Glob Antimicrob Resist. 2018 Sep;14:72-77
pubmed: 29486358
J Infect. 2015 Sep;71(3):385-94
pubmed: 26033696
Front Microbiol. 2017 Mar 22;8:464
pubmed: 28382028
J Infect. 2018 Sep;77(3):242-248
pubmed: 29932963
Environ Microbiol. 2018 Jan;20(1):270-280
pubmed: 29124846
Dan Med J. 2016 Oct;63(10):
pubmed: 27697142
Antimicrob Agents Chemother. 2016 May 23;60(6):3653-61
pubmed: 27044550
Clin Microbiol Infect. 2015 Nov;21(11):1011-7
pubmed: 26183300
Sci Rep. 2017 Feb 10;7:42537
pubmed: 28186162
J Microbiol Immunol Infect. 2014 Apr;47(2):95-103
pubmed: 23063082
Clin Microbiol Infect. 2017 Sep;23(9):672.e1-672.e11
pubmed: 28143788
J Infect. 2017 Sep;75(3):254-262
pubmed: 28648496